B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

ICAM1

MOLECULAR TARGET

intercellular adhesion molecule 1

UniProt: P05362NCBI Gene: 33831 compounds

ICAM1 (intercellular adhesion molecule 1) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting ICAM1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Lovastatin0.691

About ICAM1 as a Drug Target

ICAM1 (intercellular adhesion molecule 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented ICAM1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

ICAM1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.